Latest News and Press Releases
Want to stay updated on the latest news?
-
Neue Studie zeigt positive Ergebnisse bei der Behandlung von Palliativpatient:innen im Spätstadium mit Cannabis-basierten Arzneimitteln Bensheim – 13. Juni 2025. Laut Angaben der WHO benötigen jedes...
-
New Study Demonstrates Significant Symptom Relief for Late-Stage Palliative Patients Treated with Cannabis-based Medicines Bensheim, Germany – 13th June 2025 – According to the World Health...
-
Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial.
-
Noted pharmaceutical industry executive Frederick Beddingfield, MD, PhD, has joined the Neurodon Board of Directors, bringing years of industry leadership.
-
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
-
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
-
Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course" training has been added to ResearchAndMarkets.com's offering. This intensive three-day course will help you to...
-
New Patent issuance
-
Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75% or greater improvement in overall disease severity, the primary endpoint, in more...
-
DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- BioNTX, the leading voice of the bioscience and healthcare innovation ecosystem in North Texas, is proud to announce its attendance at the upcoming 2025 BIO...